Artificial Intelligence (AI) in Drug Discovery Market 2020: Analysis key /Trends, Industry Growth and Demand

Artificial Intelligence (AI) in Drug Discovery Market Overview

AI drug discovery has proved itself as a vital part of the drugs industry. This technology is used for regulating drug innovation & progress costs and in decreasing the processing time. Fast adoption and other features will help the global AI in the drug discovery market to touch a 41% annual growth rate. AI method uses different algorithms for improving the drug designs, their molecular structures and classification of various forms of drugs. All of the above features are adding to the tally of the market and giving it a considerable push to reach new levels of success.

Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/9393

AI in drug discovery has enlightened the workflow of medical facilities, and on the same page has helped in boosting care facilities. Extensive medical facilities have always tried to opt for better services and latest technologies with minimum space for mistakes. This technology has fastened the drug construction procedures for cases which need specialised medicinal attention, decreases failure risks and also the cost of research & development procedures. All these major features have pushed the authorities to adopt AI technology and have increased the AI in the drug discovery market.

In the absence of AI technology, any new drug development procedures can take years for development and substantial money. Apart from all these factors, AI is still a faraway story for most economies as it is costly, limited awareness and lack of skilled professional workers. These points are a major setback for the growth of the industry.

Market Segments of the Artificial Intelligence (AI) in Drug Discovery Market

The global market for AI in drug discovery is segmented into three factors:

Product type: There are three types of products, namely software, hardware and services.

Technology-based: Technologies like machine learning, deep learning, natural language processing and querying method are some examples of technology.

Application-based: AI technology is used in candidate screening, preclinical testing, target identification and others.

End-Users: Contract research organisations (CROs), pharma and biotech industries and government research facilities are some of the end-users.

Artificial Intelligence (AI) in Drug Discovery Market Regional Overview

America, Europe, Asia Pacific and The Middle East & Africa are the four markets observed for the AI in drugs discovery market.

The American region is the current market leader with the US and Canada as the major shareholding markets. Demand for new technologies, the presence of sound AI developers and increased investments in the direction of research & development are the major factors driving the market in this region. This region will maintain its position until the projected period.

The European region is the second-largest AI market. With the increasing demand for faster results and accuracy are helping the global AI in the drug discovery market grow in this region. Authorities and industries are hiring and collaborating with AI experts for easy attainment of such methods.

Asia Pacific region is in third place but will pop out as the fastest growing market in future perspective. There are continuous efforts to make this technology a common practice, and for that, companies are collaborating for better and reliable results.

The Middle East & African region is the smallest industry due to low economic developments and deliberate efforts towards creating a strong medical sector.

Recent Industry News

As a costly technology, efforts are required to develop more adaptable technologies which become suitable for all and will expand this industries base. Asia Pacific region is making substantial efforts in adopting and developing in technologies, making it the fastest-growing market on a global scale. 

Key Players

• Microsoft Corporation
• IBM Corporation
• Google (A Subsidiary of Alphabet Inc.)
• Atomwise, Inc.
• Deep Genomics
• Cloud Pharmaceuticals, Inc.
• Insilico Medicine
• BenevolentAI
• Exscientia
• Cyclica
• Bioage
• Numerate
• Numedii, Inc.
• Envisagenics
• Twoxar, Incorporated
• Owkin, Inc.
• Xtalpi, Inc.
• Verge Genomics
• Berg LLC

Read Complete Report With Toc @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Artificial Intelligence (AI) in Drug Discovery Market- Trends | Global Size, Share and Forecast

 Artificial Intelligence (AI) in Drug Discovery Market Overview

AI drug discovery has proved itself as a vital part of the drugs industry. This technology is used for regulating drug innovation & progress costs and in decreasing the processing time. Fast adoption and other features will help the global AI in the drug discovery market to touch a 41% annual growth rate. AI method uses different algorithms for improving the drug designs, their molecular structures and classification of various forms of drugs. All of the above features are adding to the tally of the market and giving it a considerable push to reach new levels of success.

Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/9393

AI in drug discovery has enlightened the workflow of medical facilities, and on the same page has helped in boosting care facilities. Extensive medical facilities have always tried to opt for better services and latest technologies with minimum space for mistakes. This technology has fastened the drug construction procedures for cases which need specialised medicinal attention, decreases failure risks and also the cost of research & development procedures. All these major features have pushed the authorities to adopt AI technology and have increased the AI in the drug discovery market.

In the absence of AI technology, any new drug development procedures can take years for development and substantial money. Apart from all these factors, AI is still a faraway story for most economies as it is costly, limited awareness and lack of skilled professional workers. These points are a major setback for the growth of the industry.

Market Segments of the Artificial Intelligence (AI) in Drug Discovery Market

The global market for AI in drug discovery is segmented into three factors:

Product type: There are three types of products, namely software, hardware and services.

Technology-based: Technologies like machine learning, deep learning, natural language processing and querying method are some examples of technology.

Application-based: AI technology is used in candidate screening, preclinical testing, target identification and others.

End-Users: Contract research organisations (CROs), pharma and biotech industries and government research facilities are some of the end-users.

Artificial Intelligence (AI) in Drug Discovery Market Regional Overview

America, Europe, Asia Pacific and The Middle East & Africa are the four markets observed for the AI in drugs discovery market.

The American region is the current market leader with the US and Canada as the major shareholding markets. Demand for new technologies, the presence of sound AI developers and increased investments in the direction of research & development are the major factors driving the market in this region. This region will maintain its position until the projected period.

The European region is the second-largest AI market. With the increasing demand for faster results and accuracy are helping the global AI in the drug discovery market grow in this region. Authorities and industries are hiring and collaborating with AI experts for easy attainment of such methods.

Asia Pacific region is in third place but will pop out as the fastest growing market in future perspective. There are continuous efforts to make this technology a common practice, and for that, companies are collaborating for better and reliable results.

The Middle East & African region is the smallest industry due to low economic developments and deliberate efforts towards creating a strong medical sector.

Recent Industry News

As a costly technology, efforts are required to develop more adaptable technologies which become suitable for all and will expand this industries base. Asia Pacific region is making substantial efforts in adopting and developing in technologies, making it the fastest-growing market on a global scale. 

Key Players

• Microsoft Corporation
• IBM Corporation
• Google (A Subsidiary of Alphabet Inc.)
• Atomwise, Inc.
• Deep Genomics
• Cloud Pharmaceuticals, Inc.
• Insilico Medicine
• BenevolentAI
• Exscientia
• Cyclica
• Bioage
• Numerate
• Numedii, Inc.
• Envisagenics
• Twoxar, Incorporated
• Owkin, Inc.
• Xtalpi, Inc.
• Verge Genomics
• Berg LLC

Read Complete Report With Toc @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Aromatherapy Market -Analysis, news, Trends, Research and Report and Demand by 2023

  

Aromatherapy is an alternative wellness treatment which is used in enhancing physical and psychological well-being. Medical applications of the treatment include wound healing, cold and cough, pain management, cardiovascular and respiratory disorders, digestion problems, and others. The global aromatherapy market report by Market Research Future (MRFR) contains estimations for the period of 2018 to 2023 (forecast period) highlighting the use of new oils and formulations used in alleviating stress levels.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3241

 

Market Scope

The global aromatherapy market size is bound to reach USD 4.3 billion by 2023, according to MRFR. It can exhibit a CAGR of 6.18% during the forecast period. It is primarily driven by the non-invasive nature of the therapy, hectic lifestyles of patients, and inclination towards alternative treatment. Burns and scars have been treated with aromatherapy. According to Plastic and Aesthetic Research, burns are accountable for close to 1 million deaths in Brazil annually.

The alternative to pharmaceutical drugs owing to awareness to its adverse effects can drive the demand for aromatherapy. For instance, rosemary oil can heal cold and cough when inhaled. Extensive research on the benefits of the treatment for cancer and other chronic diseases can widen the prospects of the market effectively. Emergence of spa and wellness centers has encouraged the growth of the therapy. Word-of-mouth publicity and advocation by clients have led to the promotion of essential oils and other equipment. Aromatherapy oils have been used in the treatment of insomnia at homes.

Strict regulations pertaining to indications and transparency of ingredients on labels can restrict the global aromatherapy market growth.

Segmentation

The global aromatherapy market is segmented on the basis of product, equipment, application, and therapeutic application. Based on the product, the market has been segmented into essential oils, blended oils, and carrier oils. The essential oils segment is sub-segmented into spicy, herbaceous/camphoraceous, floral, citrus, green/vegetative, and others. Essential oils are used in clinical aromatherapy programs for providing benefits to patients with nausea, anxiety, and other health conditions.

The equipment segment is sub segmented into nebulizer diffuser, ultrasonic diffuser and heat diffuser.

Applications of aromatherapy comprise tropical, inhalation and aerial diffusion.

Lastly, the therapeutic application segment is sub segmented into skin and hair care, relaxation and sleep, pain management, and other remedies.

Regional Analysis

The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions analyzed with respect to the scope of the global aromatherapy market.

The Americas can dominate the market primarily to patients in the U.S. opting for complementary and alternative medicine (CAM) therapies. Presence of various companies offering aromatherapy oils for relaxation and alleviation of stress levels can bode well for the market. Europe held the second-largest share of the market owing to establishment of clinics and large expendable income levels of patients. Germany, France, and the U.K. can contribute to regional market growth. The huge trade of aromatherapy products in the region will provide an impetus to the global aromatherapy market.

APAC can showcase the maximum growth owing to unmet health needs in China and India. Rise in the number of accidents and burns have spurred the demand for essential and carrier oils, effectively boosting global market growth. Lastly, the MEA aromatherapy market is likely to expand owing to Saudi Arabia and United Arab Emirates (UAE).

Competition Outlook

Muji, Tree of Life, Young Living, Air Aroma, Neal’s Yard Remedies, NOW Foods, Zija International, Nu Skin, dōTERRA, and others are key players of the global aromatherapy market. Product developments, partnerships, and expansions are prime strategies of players in the market.

 

Read  More @ https://www.marketresearchfuture.com/reports/aromatherapy-market-3241

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Body Contouring Devices and Procedures Market Trends 2020- Global Growth and Forecast

 Body Contouring Devices and Procedures Market Overview

There is a rapid rise in obesity cases in all age groups, which has increased the cases of severe health conditions. Body contouring devices and procedures are used for removing excess fat or treating the problem through various procedures. Adopting unhealthy lifestyles and habits has boosted the obesity patient counts, which has resulted in the seamless growth of this market. As technology advanced, the safety and efficiency of the procedures have increased the life expectancy, which has increased the adoption of this technology and is accelerating the market.

Free Sample Copy of  With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6935

The companies are collaborating to come out with better alternates, which is expected to provide an essential boost to this market. As the global obesity counts are increasing, the demands for better procedures are also increasing as the urbanization and rise in per capita incomes are also trending. Apart from the uses and features, the global body contouring devices and procedures market is facing severe challenges from the high costs, which has degraded the global growth, as it is unreachable for the people residing in weaker economies.

The market majors are trying to market the technique more cost-effective, less complicated, and minimally invasive, which will be beneficial for the market in future aspects. This report provides a comprehensive outlook on competition, opportunities, drivers & restraints, and other factors affecting the local and global body contouring devices and procedures market. The global market is anticipated to register approximately a 07 % annual growth during this period.

Body Contouring Devices and Procedures Market Division

The global body contouring devices and procedures market is segmented into classes as follows:

The global body contouring devices and procedures market is segmented by non-invasive devices, minimally invasive devices, laser-assisted lipolysis devices, and others based on product types.

Based on applications, the global body contouring devices and procedures market is segmented into skin tightening and fat reduction.

Based on end-users, the global body contouring devices and procedures market is segmented into research labs, hospitals, and clinics.

Body Contouring Devices and Procedures Market Regional Classification

The body contouring devices and procedures market has gained global adoption due to its rising obese population, and demands for better alternatives. The Asia Pacific, North America, Europe, and the rest of the world are the major markets studied for the global body contouring devices and procedures market. The North American region is leading the market due to the presence of key players, demands for advanced technologies, increasing research & development activities, a well-established healthcare system, rigid regulations, and other factors. The Asia Pacific region will register the fastest growth rates due to the vast population covers, rising unhealthy habits adoption, fast-developing healthcare systems, increasing healthcare issues, and other factors with India and China among the market leaders due to rapid development and presence of vast opportunities.

Industry News

The global body contouring devices and procedures market has gained a significant place as the obesity counts increase, and people are getting aware of the related hazards. The non-invasive and minimally invasive procedures will register the fastest growth. The market is currently led by the North American region, whereas the Asia Pacific region will register the fastest growth.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/body-contouring-devices-and-procedures-market-6935

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Ligation Devices Market 2020 Global Market Analysis, Demand, Key Players, Future Growth By 2023

 Market Highlights

Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,

Market research future will be publishing a Half cooked research report on “Global  ligature Devices Market” that contains the information from 2019 to 2024. Ligation Devices Market is expected to grow at a CAGR 6.7% during the forecast period of 2019 to 2024.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7794 

Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.

000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.

Regional Analysis

The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.

In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.

On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.

Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.

On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/ligation-devices-market-7794

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medication Management Market Perceive A Distinctive Growth at a CAGR 13.4% By 2023

 Medication Management Market Research Report: by systems (Computerized Physician Order Entry Systems, Administration Software, others), services (Point-Of-Care Verification Services, others), mode of delivery, end user – Global forecast till 2023

Market Insights

Market Research Future predicted that the global Medication management System market is set to reach the highest CAGR of 13.4% through the forecast period, 2018-2023.

Medication management focuses on improving medication use for the patient's condition. Interventions may include medication alignment, medication management, patient / family education about medications, and patient medication configuration simulations.

The growing geriatric population is one of the most important factors in the drug management market. Older people often have significant comorbidities that increase drug use and the risk of poor outcomes. According to a 2018 study published in Clinical Epidemiology, polypharmacy affects between 40% and 50% of older people in countries with high-income. Polypharmacy increases the risk of drug-related side effects in older people because more drugs are associated with a higher risk of harmful drug interactions. Several other factors, such as the emergence of funds in the healthcare sector and the need to reduce healthcare costs, are some of the drivers of the market.

However, the high costs of software implementation and service maintenance can hinder the market growth during the forecast period.

Market Segmentation

The global Medication management System market is segmented based on systems, services, delivery methods, and end-user.

The global system-based medication management market is divided into computerized physician order entry systems, clinical decision support systems, administration software, inventory management systems, automated dispensing systems, and assurance systems. Administration software segment is further classified as Bar Code Drug Delivery Software (BCMA) and Electronic Drug Management Software (eMAR). The automatic distributor's segment is further classified as centralized automated distribution systems and decentralized automated distribution systems (ADS). A centralized automated dosing system includes robots / dosing systems and automated carousels. The decentralized automated dispensing system (ADS) comprises automated decentralized unit dose metering systems, pharmacy-based decentralized automated dispensing systems, and service-based decentralized automated dispensing systems.

The services market segment is subdivided into point-of-care verification services and drug side effects monitoring.

The global market, on the basis of delivery mode, is divided into on-premise solutions, web-based solutions, and cloud-based solutions.

The market is segmented into pharmacies, hospitals, healthcare facilities, research institutes, and others, based on end-user.

Regional Outlook

The United States has dominated the global drug management market. This growth can be ascribed to the rise in the elderly population and the presence of the main market players in the region.

Europe ranked second in 2017 due to the presence of developed economies such as the United Kingdom, Germany, France, and other countries in the region, which is an engine for market growth.

The Asia Pacific region is likely to see the fastest growth in 2017. Factors such as health technology sector growth, increasing market penetration in the region, and growing government support for foreign investment provide regional markets in the region. Asia Pacific.

In addition, the Middle East and Africa had the lowest share of the global drug management market due to the existence of low per capita income and poor economies, especially in the African region. The Middle East region is considered an important market for the Middle East and Africa region.

 

Major Players

The leading players that are supporting the functioning of the global medication management market include General Electric Company, Siemens Ltd, Medical Information Technology, QuadraMed Affinity Corporation, Allscripts Healthcare Solutions, Cerner Corporation, Mckesson Corporation, Omnicell, Inc., Carefusion Corporation, Epic Systems Corporation, and Optum Inc.

Recent Updates

• Omnicell, Inc., a leading  of medication management solutions for healthcare and pharmacy systems, has announced that Mercy, one of five US healthcare systems for Oklahoma, Arkansas, Missouri, and Kansas, will take over the management of medication in your service network through its Omnicell's automation and intelligence solutions. Omnicell works with major healthcare systems, such as Mercy, and the company launches its vision for independent pharmacies, a step-by-step plan for developing a fully automated zero-error drug management infrastructure. Based on automation, data intelligence, and specialized services, the autonomous pharmacy will allow pharmacists, nurses, physicians, and pharmacist staff to focus on patient and physician satisfaction.

 

Read More @ https://www.marketresearchfuture.com/reports/medication-management-market-7187 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Neurovascular Devices Market 2020-Trends, Analysis by @023

 Global Market for Neurovascular Devices to Exhibit an Above-Average Growth over the Next Six Years 

Neurovascular devices are increasingly being used in for treating and management of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysm. As the global burden of neurovascular disorders continue to rise, the demand for their treatments gains further traction. Neurovascular disease are complex in nature and hence preference for minimally invasive procedures is higher. This, in turn, is driving the sales of neurovascular devices across the globe. Market Research Future (FRMR) is its latest report asserts that the global market for neurovascular devices will grow at a healthy rate over the next couple of years. 

Incessant product innovation, increased product marketing and favourable reimbursement policies are driving the global market for neurovascular devices. Other factors that are reflecting favourably on the market include expansion of the geriatric population, and advances in medical technology in the field of interventional neurology.  Moreover, neurovascular devices are also used in treating patients suffering for ischemic stroke or haemorrhagic. It has been observed that neurovascular device assisted interventional procedures are replacing the traditional neurosurgeries. Owing the low risk of damaging surrounding tissues and minimal surgical trauma, interventional procedure are more favoured as compared to neurosurgery. At the same time, chances of infection is significantly when neurovascular device based treatment. On the other hand, inadequate number of hilly skilled neurologist, particularly in developing countries expected to have a negative impact on the growth of the market. High cost of neurovascular devices continue to limit their user base despite their increased efficiency. 

Latest Industry Highlights:

• Perflow Medical, a renowned medical devices manufacturing company based in Israel, which is primarily engaged in developing novel solution for neurovascular interventions. Has recently announced that the company successfully approved a $12 Mn funding from its investors. Reportedly, the funding syndicate in included two new international investors with the existing stakeholders. 

• Junkosha a US-based company has recently introduced a unique peelable heat shrink. The technology will reportedly enable access to intricate parts of the vascular system with minimal risk of damage to the surroundings. 

Global Market for Neurovascular Devices – Segmental Analysis 

MRFR in its report has offer comprehensive segmental analysis of the market based on therapeutic application, end-user and product. By therapeutic application, the market is bifurcated into ischemic strokes and hemorrhagic stroke. Based on end user, the market is segment into ambulatory surgical units and hospitals & clinics. By product type, the market is segmented into stenting systems, neurothrombectomy devices, cerebral balloon angioplasty, aneurysm coiling & embolization devices and support device. 

Regional Overview 

The Americas is expected to hold the dominant position in the global Neurovascular Devices market for neurovascular devices. This is primarily attributed to the rising incidences of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysm across North and South America. In addition, presence of major players and rising healthcare spending among Americans is propelling the market in the region. Improved reimbursement scenario and rapid adoption of neurovascular devices in neurological centers across the region is also proving an impetus to the market. Asia Pacific and Europe are two other regions anticipated to present significant growth opportunities for market during the forecast period. 

Global Market for Neurovascular Devices – Competitive Analysis

Leading companies operating in the global market for neurovascular devices include Medtronic, TERUMO CORPORATION, Merit Medical Systems, Inc., Penumbra, Inc., Evasc, Neuravi, Sensome, Delaware Corporation, Gynesonics, Stryker, Johnson & Johnson Services, Inc., Abbott, Medikit co., ltd., MicroPort Scientific Corporation, Rapid Medical, W. L. Gore & Associates, Inc., Blockade Medical, LLC., OxfordEndovascular, and Secant Group, LLC. A majority of these market participants are actively focusing on expanding market presence by engaging in merger & acquisition and reaching offshore distribution agreements with third party vendors. 

Read More @ https://www.marketresearchfuture.com/reports/neurovascular-devices-market-5544 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com